Author

Andy Ness

Observed name: Ness, Andy

Institution: Mayo Clinic

Observed institutions: Mayo Clinic, University Hospitals Bristol NHS Foundation Trust

OpenAlex ID: A5137769544

Outcomes From the Multicenter ACCRU ‐ LY ‐1804/ CARiBOU TRIAL (Cytarabine, Acalabrutinib and Rituximab Integrated With Bortezomib‐Based Outpatient Therapy) in 1st Line Mantle Cell Lymphoma

2026 · Stephen D. Smith, Suchitra Sundaram, et al. · American Journal of Hematology

Works count: 2

Citation count:

H-index:

I10-index: